Group Post |
Boosters: US clears updated COVID boosters targeting newest variants |
mike kraft |
Group Post |
Nevada Halts Use of Rapid Coronavirus Tests in Nursing Homes, Citing Inaccuracies |
mike kraft |
Group Post |
Russia says its Sputnik V COVID-19 vaccine is 92% effective |
mike kraft |
Group Post |
Russia's Sputnik V shot around 83% effective against Delta variant, lower than previous estimate |
mike kraft |
Group Post |
How scarcity of niche biotech ingredients has slowed Covid-19 vaccine production |
mike kraft |
Group Post |
Younger, unvaccinated people appear to be driving the latest uptick in Covid-19 cases while vaccines are reducing the toll for older persons |
mike kraft |
Group Post |
Two Europes: Low vaccine rates in east Europe overwhelm ICUs |
mike kraft |
Group Post |
Covid caused huge shortages in US labor market--studies |
mike kraft |
Group Post |
Global rise in chronic diseases combined with Covid-19 bodes ill for world health |
mike kraft |
Group Post |
AstraZeneca says COVID-19 'vaccine for the world' can be 90% effective |
mike kraft |
Group Post |
What should you do if you get a breakthrough infection? Advice from an expert weighs in |
mike kraft |
Group Post |
European Union looks elsewhere to improve faltering vaccination efforts |
mike kraft |
Group Post |
Johnson & Johnson: A bad week - but fears of negative reactions and blood clots are likely overblown |
mike kraft |
Group Post |
Tensions reportedly grow between Moderna, White House over vaccine production |
mike kraft |
Group Post |
Risk of Blood Clots Is Higher than usual for the First Year After COVID-19, New Research Suggests |
mike kraft |
Group Post |
COVID's cognitive costs? Some patients' brains may age 10 years |
mike kraft |
Group Post |
Spit in a Tube and Mail It In: A New Frontier in Coronavirus Testing |
mike kraft |
Group Post |
Vaccinations: U.S vaccination rate has risen by 17 % since FDA gave full approval to Phizer vaccine |
mike kraft |
Group Post |
New study says 6-foot social distancing not necessary in classrooms |
mike kraft |
Group Post |
India’s massive COVID surge puzzles scientists, initial antibody data may have been too narrow. |
mike kraft |
Group Post |
Analysis:The U.S. may be less prepared for the next pandemic than it was for the current one because of threats, resignations and politics--NY Times survey . |
mike kraft |
Group Post |
Paxlovid: Major new study into whether it can treat long Covid |
mike kraft |
Group Post |
Explanation: Why so many vaccinated people are getting COVID-19 lately |
mike kraft |
Group Post |
Analysis: Three years since Covid-19 emerged: What have we learned and what more do we need to understand? |
mike kraft |
Group Post |
Flu Season Could Make Coronavirus Testing Delays Even Worse |
mike kraft |
Recent Comments